文献
J-GLOBAL ID:201702217864290062
整理番号:17A1017033
構造に基づくドラッグデザインを介したN-((3R,4R)-4-フルオロ-1-(6-((3-メトキシ-1-メチル-1H-ピラゾール-4-イル)アミノ)-9-メチル-9H-プリン-2-イル)ピロリジン-3-イル)アクリルアミド(PF-06747775)の発見:野生型EGFを越えた選択性で発癌性EGFR変異体に標的化する高親和性不可逆的阻害剤
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
著者 (41件):
PLANKEN Simon
(Pfizer Worldwide Res. and Dev., California, USA)
,
BEHENNA Douglas C.
(Pfizer Worldwide Res. and Dev., California, USA)
,
NAIR Sajiv K.
(Pfizer Worldwide Res. and Dev., California, USA)
,
JOHNSON Theodore O.
(Pfizer Worldwide Res. and Dev., California, USA)
,
NAGATA Asako
(Pfizer Worldwide Res. and Dev., California, USA)
,
ALMADEN Chau
(Pfizer Worldwide Res. and Dev., California, USA)
,
BAILEY Simon
(Pfizer Worldwide Res. and Dev., California, USA)
,
BALLARD T. Eric
(Pfizer Worldwide Res. and Dev., California, USA)
,
BERNIER Louise
(Pfizer Worldwide Res. and Dev., California, USA)
,
CHENG Hengmiao
(Pfizer Worldwide Res. and Dev., California, USA)
,
CHO-SCHULTZ Sujin
(Pfizer Worldwide Res. and Dev., California, USA)
,
DALVIE Deepak
(Pfizer Worldwide Res. and Dev., California, USA)
,
DEAL Judith G.
(Pfizer Worldwide Res. and Dev., California, USA)
,
DINH Dac M.
(Pfizer Worldwide Res. and Dev., California, USA)
,
EDWARDS Martin P.
(Pfizer Worldwide Res. and Dev., California, USA)
,
FERRE Rose Ann
(Pfizer Worldwide Res. and Dev., California, USA)
,
GAJIWALA Ketan S.
(Pfizer Worldwide Res. and Dev., California, USA)
,
HEMKENS Michelle
(Pfizer Worldwide Res. and Dev., California, USA)
,
KANIA Robert S.
(Pfizer Worldwide Res. and Dev., California, USA)
,
KATH John C.
(Pfizer Worldwide Res. and Dev., California, USA)
,
MATTHEWS Jean
(Pfizer Worldwide Res. and Dev., California, USA)
,
MURRAY Brion W.
(Pfizer Worldwide Res. and Dev., California, USA)
,
NIESSEN Sherry
(Pfizer Worldwide Res. and Dev., California, USA)
,
ORR Suvi T. M.
(Pfizer Worldwide Res. and Dev., California, USA)
,
PAIRISH Mason
(Pfizer Worldwide Res. and Dev., California, USA)
,
SACH Neal W.
(Pfizer Worldwide Res. and Dev., California, USA)
,
SHEN Hong
(Pfizer Worldwide Res. and Dev., California, USA)
,
SHI Manli
(Pfizer Worldwide Res. and Dev., California, USA)
,
SOLOWIEJ James
(Pfizer Worldwide Res. and Dev., California, USA)
,
TRAN Khanh
(Pfizer Worldwide Res. and Dev., California, USA)
,
TSENG Elaine
(Pfizer Worldwide Res. and Dev., California, USA)
,
VICINI Paolo
(Pfizer Worldwide Res. and Dev., California, USA)
,
WANG Yuli
(Pfizer Worldwide Res. and Dev., California, USA)
,
WEINRICH Scott L.
(Pfizer Worldwide Res. and Dev., California, USA)
,
ZHOU Ru
(Pfizer Worldwide Res. and Dev., California, USA)
,
ZIENTEK Michael
(Pfizer Worldwide Res. and Dev., California, USA)
,
LIU Longqing
(Wuxi AppTec, Shanghai, CHN)
,
LUO Yiqin
(Wuxi AppTec, Shanghai, CHN)
,
XIN Shuibo
(Wuxi AppTec, Shanghai, CHN)
,
ZHANG Chengyi
(Wuxi AppTec, Shanghai, CHN)
,
LAFONTAINE Jennifer
(Pfizer Worldwide Res. and Dev., California, USA)
資料名:
Journal of Medicinal Chemistry
(Journal of Medicinal Chemistry)
巻:
60
号:
7
ページ:
3002-3019
発行年:
2017年04月13日
JST資料番号:
D0102A
ISSN:
0022-2623
CODEN:
JMCMAR
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)